Skip to main content
graph.swiss
Carl Zeiss Meditec AG

Carl Zeiss Meditec AG

27.02 CHF+0.72 (+2.74%)
XSWX:AFXMarket Closed
ListedCHF2.3BHealthcareMedical Instruments & Supplies5,798 employees

Company Profile

Legal NameCarl Zeiss Meditec AG
CEOMr. Andreas Pecher
HeadquartersGöschwitzer Straße 51-52
Phone49 3641 220 115
Employees (FTE)5,798
SectorHealthcare
IndustryMedical Instruments & Supplies

Business Description

Carl Zeiss Meditec AG is a leading medical technology company specializing in ophthalmology and microsurgery solutions. Headquartered in Jena, Germany, and founded in 1846, it operates as a subsidiary of the ZEISS Group, delivering innovative products for diagnosing and treating eye diseases such as ametropia, cataracts, glaucoma, and retinal disorders. Its Ophthalmology segment provides diagnostic tools like slit lamps, refractometers, optical coherence tomography devices, and fundus cameras, alongside surgical equipment including microscopes, biometers, phacoemulsification systems, vitrectomy devices, intraocular lenses, and laser surgery consumables. The Microsurgery segment offers visualization and treatment solutions for neurosurgery, ear-nose-throat procedures, spine, plastic and reconstructive surgery, and dentistry. With a global presence across Europe, North America, and Asia, employing over 5,700 people, Carl Zeiss Meditec AG drives advancements in healthcare through cutting-edge technologies, digital workflow solutions, and AI-integrated systems, enhancing clinical efficiency and patient outcomes in advanced medical equipment sectors.

Profitability & Growth

Profitability

Profit Margin+4.38%
Operating Margin+4.86%
Return on Equity (TTM)+4.54%
Return on Assets (TTM)+2.74%

Recent Year-End

Revenue2.01B
Revenue / Share24.77
Gross Profit1.03B
EBITDA195.6M
Diluted EPS1.26
Earnings Growth YoY-56.80%
Revenue Growth YoY-6.40%

Balance Sheet Snapshot

Total Cash (MRQ)

22.1M

Total Debt (MRQ)

537.6M

Current Ratio (MRQ)

2.43

Book Value / Share

22.11

Stock Statistics

Shares Outstanding87.5M
Float Shares34.7M
Avg Volume (10d)1
Avg Volume (90d)0
% Held by Insiders+59.23%
% Held by Institutions+18.08%

Valuation

Market Cap2.30B
Enterprise Value2.71B
Trailing P/E18.35
PEG Ratio-0.14
Price / Sales (TTM)0.93
Price / Book (MRQ)1.05
EV / Revenue1.35
EV / EBITDA13.53

Price Summary

52-Week Low21.48
52-Week High32.80
50-Day MA24.59
200-Day MA25.74
Beta1.33

Dividends

Forward Div Rate0.50
Forward Div Yield+1.92%
Trailing Div Rate0.55
Dividend Date2019-03-22
Ex-Dividend Date2026-03-27